alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

EXHIBIT 13.1

     CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

          Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of section 1350, chapter 63 of title 18, United States Code), the
undersigned officers of Brilliance China Automotive Holdings Limited (the
"Company"), hereby certifies, to such officers' knowledge, that:

          The Annual Report on Form 20-F for the year ended December 31, 2006
(the "Report") of the Company fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained
in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.


Date: June 29, 2007                     By: /s/ QI Yumin
                                            ------------------------------------
                                            QI Yumin
                                            Chief Executive Officer


Date: June 29, 2007                     By: /s/ LEI Xiaoyang
                                            ------------------------------------
                                            LEI Xiaoyang
                                            Chief Financial Officer

          A signed original of this written statement required by Section 906
has been provided to Brilliance China Automotive Holdings Limited, and will be
retained by Brilliance China Automotive Holdings Limited and furnished to the
Securities and Exchange Commission or its staff upon request.

          This certification will not be deemed "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the
liability of that section. This certification will not be deemed to be
incorporated by reference into any filing under Securities Act of 1933 or the
Securities Exchange Act of 1934 even if the document with which it is submitted
to the Securities and Exchange Commission is so incorporated by reference.
Exhibit 99.2




                            CERTIFICATION PURSUANT TO
                                18 U.S.C. S 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly  Report of CNH Holdings  Company on Form 10-QSB
for the period ending June 30, 2002, as filed with the  Securities  and Exchange
Commission  on the date hereof (the  "Report"),  I, Charles  Stidham,  Principal
Financial and Accounting Officer of the Company,  certify, pursuant to 18 U.S.C.
S 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002,
that, to the best of my knowledge and belief:

     (1)  the Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.




/s/ Charles Stidham
Secretary/Treasurer and Director
(Principal Financial and Accounting Officer)
August 12, 2002
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED> 
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1996
<PERIOD-END>                               DEC-31-1995
<CASH>                                       1,300,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                     391,100,000
<DEPRECIATION>                            (78,200,000)
<TOTAL-ASSETS>                             458,700,000
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<COMMON>                                         1,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 192,100,000
<TOTAL-LIABILITY-AND-EQUITY>               458,700,000
<SALES>                                              0
<TOTAL-REVENUES>                           104,600,000
<CGS>                                                0
<TOTAL-COSTS>                               74,400,000
<OTHER-EXPENSES>                           (8,500,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                          13,500,000
<INCOME-PRETAX>                             25,200,000
<INCOME-TAX>                                 8,800,000
<INCOME-CONTINUING>                         16,400,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                16,400,000
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit 10.19



FIRST AMENDMENT

TO THE

PLAINS EXPLORATION & PRODUCTION COMPANY

LONG-TERM RETENTION AGREEMENT

JAMES C. FLORES



WHEREAS, Plains Exploration & Production Company (the
Company) and James C. Flores (Executive) entered into the Plains Exploration & Production Company Long-Term Retention Agreement (the Agreement) dated effective as of the 10th day of February, 2006 (the
Effective Date); and



WHEREAS, the Company
and Executive have agreed to amend the Agreement as set forth below;



NOW, THEREFORE, effective as of the Effective Date, the parties hereto agree as follows:



|1. | The following sentence shall be added to paragraph 4 of the Agreement:
|-- | ----------------------------------------------------------------------



The amount so credited to Executives Account shall then be contributed by the Company in cash, Common Stock or other property to the Trust
created under the Plan to be held by the trustee of such Trust until paid according to the terms of this Agreement, to Executive.



|2. | The words a Deferral Election or shall be stricken from the first sentence of paragraph 5 of the Agreement.
|-- | -------------------------------------------------------------------------------------------------------------



|3. | The first sentence of paragraph 6 of the Agreement shall be deleted.
|-- | --------------------------------------------------------------------



|4. | As modified herein, the Agreement is hereby ratified and affirmed in all respects.
|-- | ----------------------------------------------------------------------------------



IN WITNESS WHEREOF, the parties hereto have signed this to be effective set forth above.



PLAINS EXPLORATION & PRODUCTION COMPANY



|          |  |                                                       |  |                         |  | 
|--------- |  | ----------------------------------------------------- |  | ----------------------- |  | 
|By:       |  | /s/ John F. Wombwell                                  |  | Date: February 10, 2006
|Name:     |  | John F. Wombwell                                      |  |                        
|Title:    |  | Executive Vice President, General Counsel & Secretary |  |                        
|          | 
|Executive |  |                                                      
|          |  |                                                      
|By:       |  | /s/ James C. Flores                                   |  | Date: February 10, 2006
EXHIBIT 31.2I, Peter S. Case, Senior Vice-President of Finance, and Interim Chief Financial Officer andTreasurer of Ashworth, Inc., certify that: 1. I have reviewed this report on Form 10-Q of Ashworth, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:(a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;(b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and(c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and(b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.Date:September 9, 2005      /s/Peter S. Case     Peter S. Case  Senior Vice-President of Finance, and Interim Chief  Financial Officer and Treasurer
Exhibit 99.1




                            CERTIFICATION PURSUANT TO
                               18 U.S.C. SS 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly  Report of CNH Holdings  Company on Form 10-QSB
for the period  ending  September  30, 2002,  as filed with the  Securities  and
Exchange Commission on the date hereof (the "Report"), I, Charles Stidham, Chief
Executive  Officer of the Company,  certify,  pursuant to 18 U.S.C.  SS 1350, as
adopted pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.




/S/Charles Stidham
Chief Executive Officer
November 5, 2002
**EXHIBIT NO. 23.3**

 

**[RYDER SCOTT COMPANY LETTERHEAD]**

 

**CONSENT OF RYDER SCOTT COMPANY, L.P.**

 

As independent oil and gas consultants, Ryder Scott Company, L.P. hereby consents to the incorporation by reference in this Annual Report on Form 10-K ofPlains Exploration & Production Company, as well as in the Notes to the Consolidated Financial Statements included in such Form 10-K, of information from our reserve reports for Plains Exploration and Production Company and subsidiaries(collectively, the Company), as of December 31, 2003 and December 31, 2002, relating to the estimated quantities of certain of the Company’s proved reserves of oil and gas and undiscounted and discounted future net income therefrom for thespecific periods cited. We further consent to references to our firm under the headings “Oil and Gas Reserves” and “Supplemental reserve information (unaudited)”. 

 

We also consent to the incorporation by reference of such reports in the Registration Statements on Form S-8 (No.333-102627, No. 333-107990, No. 333-115628 and No. 333-117425) and Form S-3 (No. 333-112027) of Plains Exploration & Production Company. 

 

 

Houston, Texas 

March 15, 2005
<PAGE>

                                        
                                  EXHIBIT 11.1

                  SHARES USED IN EARNINGS PER SHARE COMPUTATION
                            (unaudited, in thousands)



                                                           Three Months Ended
                                                           ------------------
                                                         March 31,     March 31,
                                                           1997          1996
                                                         --------      --------
Primary
   Average shares outstanding                              23,324        25,100
   Net effect of dilutive stock options-
     based on the treasury stock method
     using average market price                               544           939
                                                           ------        ------
   Total                                                   23,868        26,039
                                                           ------        ------
                                                           ------        ------

   Net Income                                              $7,209        $6,717
                                                            -----         -----
                                                            -----         -----

   Per share amount                                         $0.30         $0.26
                                                             ----          ----
                                                             ----          ----
Fully diluted
   Average shares outstanding                              23,324        25,100
   Net effect of dilutive stock options-
     based on the treasury stock method
     using the year-end market price, if
     higher than average market price                         545         1,115
                                                            -----         -----
   Total                                                   23,869        26,215
                                                           ------        ------
                                                           ------        ------

   Net Income                                              $7,209        $6,717
                                                            -----         -----
                                                            -----         -----

   Per share amount                                         $0.30         $0.26
                                                             ----          ----
                                                             ----          ----


                                       21
# Freedom of Information Act (FOIA)

The Freedom of Information Act (FOIA, 5 U.S.C. 552) provides individuals with a right to access to records in the possession of the federal government. The government may withhold information pursuant to the nine exemptions and three exclusions contained in the Act.

If you have questions regarding FOIA requests pending with NIDCD or questions specific to NIDCD records, please contact Amy Yang, NIDCD FOIA coordinator, by phone (301-347-8566) or email. To read about the types of information you can request through FOIA or submit a FOIA request with NIH, visit the National Institutes of Health FOIA page.

July 27, 2023
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               MAR-31-1998
<CASH>                                       4,247,000
<SECURITIES>                                         0
<RECEIVABLES>                                2,520,000
<ALLOWANCES>                                         0
<INVENTORY>                                 74,379,000
<CURRENT-ASSETS>                            81,146,000
<PP&E>                                       2,031,000
<DEPRECIATION>                                 780,000
<TOTAL-ASSETS>                              88,281,000
<CURRENT-LIABILITIES>                       31,041,000
<BONDS>                                     30,925,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       141,000
<OTHER-SE>                                  26,174,000
<TOTAL-LIABILITY-AND-EQUITY>                88,281,000
<SALES>                                    160,830,000
<TOTAL-REVENUES>                           160,830,000
<CGS>                                      139,284,000
<TOTAL-COSTS>                              139,284,000
<OTHER-EXPENSES>                            20,541,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,018,000
<INCOME-PRETAX>                            (1,013,000)
<INCOME-TAX>                                 (415,000)
<INCOME-CONTINUING>                          (598,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (598,000)
<EPS-PRIMARY>                                    (.10)
<EPS-DILUTED>                                    (.10)
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          11,798
<SECURITIES>                                         0
<RECEIVABLES>                                  101,088
<ALLOWANCES>                                       508
<INVENTORY>                                     35,839
<CURRENT-ASSETS>                               151,980
<PP&E>                                         701,139
<DEPRECIATION>                                 372,660
<TOTAL-ASSETS>                                 533,699
<CURRENT-LIABILITIES>                          118,159
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     207,973
<TOTAL-LIABILITY-AND-EQUITY>                   533,699
<SALES>                                        532,626
<TOTAL-REVENUES>                               532,626
<CGS>                                          495,287
<TOTAL-COSTS>                                  495,287
<OTHER-EXPENSES>                                20,159
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,391
<INCOME-PRETAX>                                    789
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                789
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       789
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02
        

</TABLE>
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2541 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2541

 To extend the temporary suspension of duty on Ethanesulfonic acid, 2-
[[[2,5-dichloro-4-[(2-methyl-1H-indol-3-yl)azo]phenyl]sulfonyl]amino]-, 
                            monosodium salt.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 30, 2009

   Mr. Burr introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on Ethanesulfonic acid, 2-
[[[2,5-dichloro-4-[(2-methyl-1H-indol-3-yl)azo]phenyl]sulfonyl]amino]-, 
                            monosodium salt.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ETHANESULFONIC ACID, 2-[[[2,5-DICHLORO-4-[(2-METHYL-1H-
              INDOL-3-YL)AZO]PHENYL]SULFONYL]AMINO]-, MONOSODIUM SALT.

    (a) In General.--Heading 9902.24.98 of the Harmonized Tariff 
Schedule of the United States (relating to Ethanesulfonic acid, 2-
[[[2,5-dichloro-4-[(2-methyl-1H-indol-3-yl)azo]phenyl]sulfonyl]amino]-, 
monosodium salt) is amended by striking ``12/31/2009'' and inserting 
``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
-  Home 
        -  Research & Funding 
        -  Current Funding Opportunities 
        -  Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) 

View Current Funding Opportunities

# Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Although all of the participating NIH Institutes and Centers (ICs) use this support mechanism to support career development experiences that lead to research independence, some ICs use the K01 award for individuals who propose to train in a new field or for individuals who have had a hiatus in their research career because of illness or pressing family circumstances. Other ICs offer separate K01 FOAs intended to increase research workforce diversity.

### Funding Opportunity Details

Full Announcement:PA-20-190Related Notices or Announcements:NOT-DK-21-002

Program Contact:

K01 - Research Scientist Development Award

### Key Dates

Open Date:            5/12/2020        

Letter of Intent Due Date:            Not Applicable        

Application Due Date:
Standard dates apply.

The first standard application due date for this FOA is June 12, 2020.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.